Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01366391Phase 4Unknown

Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome

Role: lead

NCT01367054Not ApplicableUnknown

Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg

Role: lead

NCT01338623Phase 4Unknown

Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State

Role: lead

All 3 trials loaded